| Treatment Group |
Uric Acid (mg/dl) |
Urea (mg/dl) |
Creatinine (mg/dl) |
| Normal |
8.036 ± 0.3514 |
31.94 ± 1.7808 |
1.15 ± 0.09615 |
| Dibetic Control |
16.243 ± 0.962a* |
55.16 ± 3.0162a* |
2.55 ± 0.2826* |
| Diabetic+CLA |
10.58 ± 0.6904** |
42.23 ± 2.3531** |
1.63 ± 0.01767** |
| Diabetic+Fish oil |
11.626 ± 0.6688** |
45.07 ± 1.4975** |
1.54 ± 0.15560** |
| Diabetic+Glibenclemide |
9.69 ± 0.3626** |
34.41 ± 2.6469a** |
1.00 ± 0.2343** |
|
| ¶serum Uric acid, Urea and cretinine in the treated rats were significantly different from normal and diabetic control groups at P<0.05; a: P<0.01* indicated the difference from normal group; whereas ** indicated the difference from Diabetic control group |
| Table 4: Effect of CLA and T. ilisha fish oil on serum Uric acid, Urea and cretinine on control and experimental rats (mean ± SEM). |
